Emily Schueddig
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Emily Schueddig has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Devin C. Koestler
Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, USA
10 shared publications - Adam D. Scheid
The University of Kansas Medical Center 1 Department of Cancer Biology Kansas City, Kansas
9 shared publications - Danny R. Welch
The University of Kansas Medical Center
9 shared publications - Isidore Rigoutsos
Computational Medicine Center, Thomas Jefferson University
9 shared publications - Katy L. Swancutt
The University of Texas Southwestern Medical Center
9 shared publications - Richard McKinnon Walsh
The University of Kansas Medical Center 1 Department of Cancer Biology Kansas City, Kansas
9 shared publications
Latest Publications
- 29 September 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
Chronic mitochondrial DNA depletion alters MAPT splicing and increases tau levels
Background: In Alzheimer's disease (AD), tau protein aggregates to form neurofibrillary tangles (NFTs). The cellular changes favoring AD brain NFT formation remain incompletely understood. AD brains also display mitochondrial defects, including reduced mitochondrial DNA (mtDNA) copy number. Objective: We considered whether mtDNA depletion alters tau homeostasis. Methods: We assessed tau mRNA using short-read mRNA sequencing and PCR, and tau protein using immunochemistry, in SH-SY5Y cells with chronic mtDNA depletion (ρ0). Results: mtDNA depletion increased tau expression and resulted in alternatively spliced isoforms, elevated 4R and exon 4a-containing MAPT transcripts, and consistently detectable big tau protein. ρ0 cells also displayed an elevated MAPT exon 13 3’Untranslated Region (UTR): Coding DNA sequence (CDS) ratio. Phosphorylation at amino acid positions 217 and 181 decreased. Conclusions: Mitochondrial dysfunction affects tau expression, splicing, and 3’UTR retention while increasing tau protein levels and modifying its phosphorylation. These studies hold AD relevance as they provide evidence for a relationship between two AD-associated phenomena, defective mitochondrial function and altered MAPT regulation.
- 29 September 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
Chronic mitochondrial DNA depletion alters MAPT splicing and increases tau levels
Background: In Alzheimer's disease (AD), tau protein aggregates to form neurofibrillary tangles (NFTs). The cellular changes favoring AD brain NFT formation remain incompletely understood. AD brains also display mitochondrial defects, including reduced mitochondrial DNA (mtDNA) copy number. Objective: We considered whether mtDNA depletion alters tau homeostasis. Methods: We assessed tau mRNA using short-read mRNA sequencing and PCR, and tau protein using immunochemistry, in SH-SY5Y cells with chronic mtDNA depletion (ρ0). Results: mtDNA depletion increased tau expression and resulted in alternatively spliced isoforms, elevated 4R and exon 4a-containing MAPT transcripts, and consistently detectable big tau protein. ρ0 cells also displayed an elevated MAPT exon 13 3’Untranslated Region (UTR): Coding DNA sequence (CDS) ratio. Phosphorylation at amino acid positions 217 and 181 decreased. Conclusions: Mitochondrial dysfunction affects tau expression, splicing, and 3’UTR retention while increasing tau protein levels and modifying its phosphorylation. These studies hold AD relevance as they provide evidence for a relationship between two AD-associated phenomena, defective mitochondrial function and altered MAPT regulation.
- Open Access
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Figure 3 from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
AlphaFold3 predictive modeling of mt-TR suggests different stability and D–T-loop structures among strains. A, Sequences for each mt-TR (from left to right: C, H, and F) modeled without posttranscriptional modifications (PTM) and displayed predicted instability/low confidence. Predicted template modeling “pTM” scores range from 0.26 to 0.28 on a scale of 0–1. B, Three rows of images are displayed with increased zoom from top to bottom. To improve confidence predictions and better reflect known principles of tRNA folding (37), sequences for each strain were modeled according to reported PTM of human mt-TR (m1A, m2G, and Ψ; ref. 31). PTM inclusion increased predicted stability and confidence scoring compared with that of unmodified sequences (pTM range, 0.75–0.77 vs. 0.26–0.28). The D–T-loop interactions have the lowest scoring confidence, which aligns with the commonly observed transcript end (Table 1) of fragments between C: U53/G54; H: U55/G56; F: U54/G55 (highlighted in green in the bottom two rows of images). Nucleotides and structure of predicted interactions between the D–T-loop differ across strains: T-loop G54 is predicted to interact with the D-loop in C mt-TR; T-loop U57 is predicted to interact with the D-loop in H mt-TR; both U54/G55 are predicted to interact specifically with A17 of the T-loop in C mt-TR. Specific predictive bonding and distances between the center of nucleotides are listed in tRF patterns in liver tissue. pIDDT, predicted local distance difference test.
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 3 from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
AlphaFold3 predictive modeling of mt-TR suggests different stability and D–T-loop structures among strains. A, Sequences for each mt-TR (from left to right: C, H, and F) modeled without posttranscriptional modifications (PTM) and displayed predicted instability/low confidence. Predicted template modeling “pTM” scores range from 0.26 to 0.28 on a scale of 0–1. B, Three rows of images are displayed with increased zoom from top to bottom. To improve confidence predictions and better reflect known principles of tRNA folding (37), sequences for each strain were modeled according to reported PTM of human mt-TR (m1A, m2G, and Ψ; ref. 31). PTM inclusion increased predicted stability and confidence scoring compared with that of unmodified sequences (pTM range, 0.75–0.77 vs. 0.26–0.28). The D–T-loop interactions have the lowest scoring confidence, which aligns with the commonly observed transcript end (Table 1) of fragments between C: U53/G54; H: U55/G56; F: U54/G55 (highlighted in green in the bottom two rows of images). Nucleotides and structure of predicted interactions between the D–T-loop differ across strains: T-loop G54 is predicted to interact with the D-loop in C mt-TR; T-loop U57 is predicted to interact with the D-loop in H mt-TR; both U54/G55 are predicted to interact specifically with A17 of the T-loop in C mt-TR. Specific predictive bonding and distances between the center of nucleotides are listed in tRF patterns in liver tissue. pIDDT, predicted local distance difference test.
- Open Access
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Figure 2 from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
TRF patterns are consistent across probed regions but differ by tissue and sex. A–F,mt-TR (71–73 nt in length) and tRF detected via Northern blotting using Probe R3 (A and D), R4 (B and E), or R5 (C and F) in male (A–C) or female (D–F) lung tissue. G, Side-by-side comparison of tRF patterns in female liver vs. lung tissues. H, Side-by-side comparison of tRF patterns in liver tissue of male vs. female mice.
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 2 from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
TRF patterns are consistent across probed regions but differ by tissue and sex. A–F,mt-TR (71–73 nt in length) and tRF detected via Northern blotting using Probe R3 (A and D), R4 (B and E), or R5 (C and F) in male (A–C) or female (D–F) lung tissue. G, Side-by-side comparison of tRF patterns in female liver vs. lung tissues. H, Side-by-side comparison of tRF patterns in liver tissue of male vs. female mice.
- Open Access
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
AlphaFold3 predictive modeling of D-T Loop interactions of mt-TR.
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
AlphaFold3 predictive modeling of D-T Loop interactions of mt-TR.
- Open Access
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
Metabolomic analysis of female MNX or WT mouse lung tissue.
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
Metabolomic analysis of female MNX or WT mouse lung tissue.
- Open Access
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
AlphaFold3 predictive modeling of D-T Loop interactions of mt-TR
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
AlphaFold3 predictive modeling of D-T Loop interactions of mt-TR
- Open Access
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Table 1 from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
Candidate tRF sequences aligned to mt-TR determined via RNA sequencing.
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable 1 from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
Candidate tRF sequences aligned to mt-TR determined via RNA sequencing.
- Open Access
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
Top ten most abundant sequences aligning to mt-TR in each sample normalized to total mapped reads (in reads per million, RPM). Notable low overall abundance of sequences from pre-treated small RNA extracted from female mouse liver reflects technical challenges in the state of the art of RNA sequencing of tRNA and tRF (n = 3 samples per WT or MNX strain).
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
Top ten most abundant sequences aligning to mt-TR in each sample normalized to total mapped reads (in reads per million, RPM). Notable low overall abundance of sequences from pre-treated small RNA extracted from female mouse liver reflects technical challenges in the state of the art of RNA sequencing of tRNA and tRF (n = 3 samples per WT or MNX strain).
- Open Access
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Data from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
How mitochondrial DNA (mtDNA) polymorphisms influence complex phenotypes remains poorly understood. Using mitochondrial–nuclear exchange mice, we previously showed that mtDNA single-nucleotide polymorphisms (SNP) modify metastasis, cardiovascular disease, and epigenetic marks independently of metabolic differences. The only mtDNA SNP correlating with these phenotypes resides in the gene encoding mitochondrial transfer RNA (tRNA)-arginine [mt-tRNAArg (UCG), mt-TR], suggesting a role for non–protein-coding loci. In this study, we identify and preliminarily characterize previously undescribed tRNA-derived fragments (tRF) generated from mt-TRs. Northern blotting revealed distinct tRF that are differentially expressed among mtDNA SNPs, between lung and liver, and between sexes. Surprisingly, small RNA sequencing of untreated RNA did not detect the same tRFs in high abundance. However, demethylating and restoring 5′-OH and 3′-PO4 termini allowed detection of sequences consistent with the northern blot bands. Enforcing exact matching to the mitochondrial genome and normalizing to their parental molecule revealed putative tRF sequences with shared cleavage sites. Based on connections among mtDNA SNPs, the resulting SNP-dependent tRF, and SNP–metastasis correlation, we propose that these tRFs may function as metastasis modifiers. These data also expand the functional output of the mitochondrial genome that can contribute to phenotype modification. Significance:This study describes identification and initial characterization of mitochondrial tRNA fragments that are suspected to regulate metastasis efficiency.
- 28 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
How mitochondrial DNA (mtDNA) polymorphisms influence complex phenotypes remains poorly understood. Using mitochondrial–nuclear exchange mice, we previously showed that mtDNA single-nucleotide polymorphisms (SNP) modify metastasis, cardiovascular disease, and epigenetic marks independently of metabolic differences. The only mtDNA SNP correlating with these phenotypes resides in the gene encoding mitochondrial transfer RNA (tRNA)-arginine [mt-tRNAArg (UCG), mt-TR], suggesting a role for non–protein-coding loci. In this study, we identify and preliminarily characterize previously undescribed tRNA-derived fragments (tRF) generated from mt-TRs. Northern blotting revealed distinct tRF that are differentially expressed among mtDNA SNPs, between lung and liver, and between sexes. Surprisingly, small RNA sequencing of untreated RNA did not detect the same tRFs in high abundance. However, demethylating and restoring 5′-OH and 3′-PO4 termini allowed detection of sequences consistent with the northern blot bands. Enforcing exact matching to the mitochondrial genome and normalizing to their parental molecule revealed putative tRF sequences with shared cleavage sites. Based on connections among mtDNA SNPs, the resulting SNP-dependent tRF, and SNP–metastasis correlation, we propose that these tRFs may function as metastasis modifiers. These data also expand the functional output of the mitochondrial genome that can contribute to phenotype modification. Significance:This study describes identification and initial characterization of mitochondrial tRNA fragments that are suspected to regulate metastasis efficiency.
- Open Access
- 1 August 2026
- Published by American Association for Cancer Research (AACR) in Cancer Research Communications
- Vol. 6 (8) , 2017-2025
Mitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
How mitochondrial DNA (mtDNA) polymorphisms influence complex phenotypes remains poorly understood. Using mitochondrial–nuclear exchange mice, we previously showed that mtDNA single-nucleotide polymorphisms (SNP) modify metastasis, cardiovascular disease, and epigenetic marks independently of metabolic differences. The only mtDNA SNP correlating with these phenotypes resides in the gene encoding mitochondrial transfer RNA (tRNA)-arginine [mt-tRNAArg (UCG), mt-TR], suggesting a role for non–protein-coding loci. In this study, we identify and preliminarily characterize previously undescribed tRNA-derived fragments (tRF) generated from mt-TRs. Northern blotting revealed distinct tRF that are differentially expressed among mtDNA SNPs, between lung and liver, and between sexes. Surprisingly, small RNA sequencing of untreated RNA did not detect the same tRFs in high abundance. However, demethylating and restoring 5′-OH and 3′-PO4 termini allowed detection of sequences consistent with the northern blot bands. Enforcing exact matching to the mitochondrial genome and normalizing to their parental molecule revealed putative tRF sequences with shared cleavage sites. Based on connections among mtDNA SNPs, the resulting SNP-dependent tRF, and SNP–metastasis correlation, we propose that these tRFs may function as metastasis modifiers. These data also expand the functional output of the mitochondrial genome that can contribute to phenotype modification. Significance: This study describes identification and initial characterization of mitochondrial tRNA fragments that are suspected to regulate metastasis efficiency.
- 1 August 2026
- Published by American Association for Cancer Research (AACR) in Cancer Research Communications
- Vol. 6 (8) , 2017-2025
Open AccessMitochondrial tRNA-Derived Fragments as Candidate Metastasis-Modifying RNA
How mitochondrial DNA (mtDNA) polymorphisms influence complex phenotypes remains poorly understood. Using mitochondrial–nuclear exchange mice, we previously showed that mtDNA single-nucleotide polymorphisms (SNP) modify metastasis, cardiovascular disease, and epigenetic marks independently of metabolic differences. The only mtDNA SNP correlating with these phenotypes resides in the gene encoding mitochondrial transfer RNA (tRNA)-arginine [mt-tRNAArg (UCG), mt-TR], suggesting a role for non–protein-coding loci. In this study, we identify and preliminarily characterize previously undescribed tRNA-derived fragments (tRF) generated from mt-TRs. Northern blotting revealed distinct tRF that are differentially expressed among mtDNA SNPs, between lung and liver, and between sexes. Surprisingly, small RNA sequencing of untreated RNA did not detect the same tRFs in high abundance. However, demethylating and restoring 5′-OH and 3′-PO4 termini allowed detection of sequences consistent with the northern blot bands. Enforcing exact matching to the mitochondrial genome and normalizing to their parental molecule revealed putative tRF sequences with shared cleavage sites. Based on connections among mtDNA SNPs, the resulting SNP-dependent tRF, and SNP–metastasis correlation, we propose that these tRFs may function as metastasis modifiers. These data also expand the functional output of the mitochondrial genome that can contribute to phenotype modification. Significance: This study describes identification and initial characterization of mitochondrial tRNA fragments that are suspected to regulate metastasis efficiency.